Related Experiment Video
Updated: Jul 25, 2025

05:26
Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
9.3K
Ventilator Management in Metformin-Associated Lactic Acidosis: A Case Report.
Michael A Frakes1, Jackson McWade2, Vahé Ender1
1Boston MedFlight, Bedford, MA.
Air Medical Journal
|June 25, 2023
Summary
Mechanical ventilation for severe metabolic acidosis is challenging. Slightly increasing tidal volume in patients without ARDS can help maintain acid-base balance during ventilation.
Area of Science:
- Critical Care Medicine
- Pulmonology
- Nephrology
Background:
- Mechanical ventilation initiation in profound metabolic acidosis presents unique challenges, especially during transport.
- Traditional guidelines suggest avoiding intubation in severe acidemia due to impaired patient-ventilator synchrony.
- Metformin-associated lactic acidosis (MALA) is a critical condition requiring careful management.
Observation:
- A patient with MALA (pH 6.51) required intubation due to altered mental status and airway protection issues.
- Maintaining adequate minute ventilation conflicts with the standard low tidal volume ventilation strategy.
- The patient had profound metabolic acidosis but no signs of acute respiratory distress syndrome (ARDS).
Findings:
- Clinician-managed mechanical ventilation can be less effective than patient's own compensatory ventilation in severe acidemia.
- Slightly increasing tidal volume in MALA patients without ARDS can improve respiratory efficiency.
- This strategy aids in maintaining acid-base homeostasis during mechanical ventilation.
Implications:
- Ventilatory strategies for metabolic acidosis may need individualization beyond standard low tidal volume protocols.
- Careful consideration of tidal volume adjustments can be crucial for managing acid-base status in specific patient populations.
- This approach may offer a viable alternative for managing patients with severe metabolic acidosis requiring mechanical ventilation.
Related Concept Videos
Oral Hypoglycemic Agents: Biguanides and Glitazones
240
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
240
Acute Respiratory Failure-V
169
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
169
Acute Respiratory Failure-III
232
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
232
Heart Failure V: Medical Management
15
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
15
Insulin: Dosing Regimen and Adverse Effects
214
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
214
Heart Failure Drugs: Inotropic Agents
640
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
640

